Company Filing History:
Years Active: 2021
Title: The Innovations of Peter Shahinian
Introduction
Peter Shahinian is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of biotechnology, particularly in the development of replicons for flaviviruses. His work has implications for vaccine development and therapeutic protein expression.
Latest Patents
Peter Shahinian holds a patent for his invention titled "Flavivirus replicons." This invention provides improved replicons and vectors that encode sustained expression of an encoded protein. The replicons include flavivirus replicases and heterologous protein coding sequences, which are flanked by separation sequences to enhance efficacy. The nucleic acids developed through this invention, including self-replicating RNAs, are valuable for methods of protein expression, such as vaccines and therapeutic proteins like antibodies.
Career Highlights
Peter Shahinian is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis focuses on advancing biotechnological innovations that can lead to significant medical breakthroughs. His expertise in the field has positioned him as a key player in the development of new therapeutic solutions.
Collaborations
Peter has collaborated with notable colleagues, including Caitlin Jeanette Hagen and Dong Yu. These collaborations have fostered an environment of innovation and have contributed to the success of their projects.
Conclusion
Peter Shahinian's contributions to the field of biotechnology, particularly through his patent on flavivirus replicons, highlight his role as an influential inventor. His work continues to pave the way for advancements in vaccine development and therapeutic applications.